These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31661990)

  • 1. The evolution in our understanding of the genetics of rheumatoid arthritis and the impact on novel drug discovery.
    Machaj F; Rosik J; Szostak B; Pawlik A
    Expert Opin Drug Discov; 2020 Jan; 15(1):85-99. PubMed ID: 31661990
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic susceptibility to rheumatoid arthritis and its implications for novel drug discovery.
    Yarwood A; Eyre S; Worthington J
    Expert Opin Drug Discov; 2016 Aug; 11(8):805-13. PubMed ID: 27267163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Polymorphisms Associated with Rheumatoid Arthritis Development and Antirheumatic Therapy Response.
    Mikhaylenko DS; Nemtsova MV; Bure IV; Kuznetsova EB; Alekseeva EA; Tarasov VV; Lukashev AN; Beloukhova MI; Deviatkin AA; Zamyatnin AA
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genomics-based systems approach towards drug repositioning for rheumatoid arthritis.
    Xu R; Wang Q
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):518. PubMed ID: 27557330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis.
    Aterido A; Cañete JD; Tornero J; Blanco F; Fernández-Gutierrez B; Pérez C; Alperi-López M; Olivè A; Corominas H; Martínez-Taboada V; González I; Fernández-Nebro A; Erra A; López-Lasanta M; López Corbeto M; Palau N; Marsal S; Julià A
    Front Immunol; 2019; 10():1459. PubMed ID: 31312201
    [No Abstract]   [Full Text] [Related]  

  • 6. Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy.
    Alam J; Jantan I; Bukhari SNA
    Biomed Pharmacother; 2017 Aug; 92():615-633. PubMed ID: 28582758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of IL17A and IL17F genes with rheumatoid arthritis disease and the impact of genetic polymorphisms on response to treatment.
    Marwa OS; Kalthoum T; Wajih K; Kamel H
    Immunol Lett; 2017 Mar; 183():24-36. PubMed ID: 28143790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of rheumatoid arthritis: Unraveling the conundrum.
    Zampeli E; Vlachoyiannopoulos PG; Tzioufas AG
    J Autoimmun; 2015 Dec; 65():1-18. PubMed ID: 26515757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy.
    Tarnowski M; Paradowska-Gorycka A; Dąbrowska-Zamojcin E; Czerewaty M; Słuczanowska-Głąbowska S; Pawlik A
    Expert Opin Drug Metab Toxicol; 2016; 12(1):41-55. PubMed ID: 26609565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of rheumatoid arthritis contributes to biology and drug discovery.
    Okada Y; Wu D; Trynka G; Raj T; Terao C; Ikari K; Kochi Y; Ohmura K; Suzuki A; Yoshida S; Graham RR; Manoharan A; Ortmann W; Bhangale T; Denny JC; Carroll RJ; Eyler AE; Greenberg JD; Kremer JM; Pappas DA; Jiang L; Yin J; Ye L; Su DF; Yang J; Xie G; Keystone E; Westra HJ; Esko T; Metspalu A; Zhou X; Gupta N; Mirel D; Stahl EA; Diogo D; Cui J; Liao K; Guo MH; Myouzen K; Kawaguchi T; Coenen MJ; van Riel PL; van de Laar MA; Guchelaar HJ; Huizinga TW; Dieudé P; Mariette X; Bridges SL; Zhernakova A; Toes RE; Tak PP; Miceli-Richard C; Bang SY; Lee HS; Martin J; Gonzalez-Gay MA; Rodriguez-Rodriguez L; Rantapää-Dahlqvist S; Arlestig L; Choi HK; Kamatani Y; Galan P; Lathrop M; ; ; Eyre S; Bowes J; Barton A; de Vries N; Moreland LW; Criswell LA; Karlson EW; Taniguchi A; Yamada R; Kubo M; Liu JS; Bae SC; Worthington J; Padyukov L; Klareskog L; Gregersen PK; Raychaudhuri S; Stranger BE; De Jager PL; Franke L; Visscher PM; Brown MA; Yamanaka H; Mimori T; Takahashi A; Xu H; Behrens TW; Siminovitch KA; Momohara S; Matsuda F; Yamamoto K; Plenge RM
    Nature; 2014 Feb; 506(7488):376-81. PubMed ID: 24390342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for rheumatoid arthritis.
    Voulgari PV
    Expert Opin Emerg Drugs; 2008 Mar; 13(1):175-96. PubMed ID: 18321156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics: a new interpretation of genetic studies in RA.
    Neidhart M; Karouzakis E
    Nat Rev Rheumatol; 2014 Apr; 10(4):199-200. PubMed ID: 24567061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of patents on anti-rheumatoid arthritis therapies issued in China.
    Yuan HY; Zhang XL; Zhang XH; Meng L; Wei JF
    Expert Opin Ther Pat; 2015; 25(8):909-30. PubMed ID: 26066366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Going with the flow: harnessing the power of the vasculature for targeted therapy in rheumatoid arthritis.
    Ferrari M; Onuoha SC; Pitzalis C
    Drug Discov Today; 2016 Jan; 21(1):172-179. PubMed ID: 26523772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review on Rheumatoid Arthritis Interventions and Current Developments.
    Khanna N; Kumar A; Pawar SV
    Curr Drug Targets; 2021; 22(4):463-483. PubMed ID: 33243118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visfatin as a therapeutic target for rheumatoid arthritis.
    Franco-Trepat E; Alonso-Pérez A; Guillán-Fresco M; Jorge-Mora A; Gualillo O; Gómez-Reino JJ; Gómez Bahamonde R
    Expert Opin Ther Targets; 2019 Jul; 23(7):607-618. PubMed ID: 31074669
    [No Abstract]   [Full Text] [Related]  

  • 17. Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.
    Bek S; Bojesen AB; Nielsen JV; Sode J; Bank S; Vogel U; Andersen V
    Pharmacogenomics J; 2017 Oct; 17(5):403-411. PubMed ID: 28607508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-TNF treatment in rheumatoid arthritis.
    Geiler J; Buch M; McDermott MF
    Curr Pharm Des; 2011; 17(29):3141-54. PubMed ID: 21864263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapies for rheumatoid arthritis.
    Tremoulet AH; Albani S
    Expert Opin Investig Drugs; 2006 Nov; 15(11):1427-41. PubMed ID: 17040201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD20 antibody rituximab in the treatment of rheumatoid arthritis.
    Korhonen R; Moilanen E
    Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):13-21. PubMed ID: 19686542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.